Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Antibacterial activity against drug resistant Mycoplasma pneumoniae assessed as inhibition of bacterial growth incubated for 18 hrs by two-fold serial dilution method
Assay data:8 Tested
SummaryPubMed Citation
Antibacterial activity against Mycoplasma pneumoniae ATCC29342 assessed as inhibition of bacterial growth incubated for 18 hrs by two-fold serial dilution method
Antibacterial activity against Mycoplasma pneumoniae ATCC15531 assessed as inhibition of bacterial growth incubated for 18 hrs by two-fold serial dilution method
Antibacterial activity against erythromycin-resistant Mycoplasma pneumoniae A2058T by microbroth dilution method
Assay data:3 Tested
Antibacterial activity against erythromycin-resistant Mycoplasma pneumoniae A2059G by microbroth dilution method
Antibacterial activity against erythromycin-resistant Mycoplasma pneumoniae A2058G by microbroth dilution method
Antibacterial activity against erythromycin-susceptible Mycoplasma pneumoniae ATCC 29342 by microbroth dilution method
Antibacterial activity against Mycoplasma pneumoniae assessed as inhibition of bacterial growth
Assay data:1 Tested
Antimycoplasmal activity against Mycoplasma pneumoniae K7 after 3 to 5 days by broth microdilution method
Ratio of MIC for levofloxacin to compound MIC for Mycoplasma pneumoniae 18-1
Ratio of MIC for levofloxacin to compound MIC for Mycoplasma pneumoniae ATCC 29085
Antimicrobial activity against Mycoplasma pneumoniae ATCC 29342 infected in BALB/c mouse assessed as decrease in bacterial infection-induced parenchymal cell histopathology at 10 mg/kg, sc on first day followed by regimen of 5 mg/kg for 5 days measured after 3 days
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed Citation
Antimicrobial activity against Mycoplasma pneumoniae ATCC 29342 infected in BALB/c mouse assessed as decrease in bacterial infection-induced lung histopathology at 10 mg/kg, sc on first day followed by regimen of 5 mg/kg for 5 days measured after 3 days
Antimicrobial activity against Mycoplasma pneumoniae ATCC 29342 infected in BALB/c mouse assessed as decrease in bacterial count in bronchoalveolar lavage fluid at 10 mg/kg, sc on first day followed by regimen of 5 mg/kg for 5 days measured after 6 days
Bactericidal activity against Mycoplasma pneumoniae assessed as log reduction in bacterial load at MIC after 72 hrs
Bactericidal activity against Mycoplasma pneumoniae assessed as log reduction in bacterial load at MIC after 24 hrs
Antimicrobial activity against Mycoplasma pneumoniae isolate FH by agar dilution method
Antimicrobial activity against Mycoplasma pneumoniae isolate M129 by agar dilution method
Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae with 23S rRNA A2064G mutant isolate 4
Assay data:5 Tested
Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae with 23S rRNA A2064G mutant isolate 2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on